The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scientific versus commercial sources of influence on the prescribing behavior of physicians
Avorn, J., Chen, M., & Hartley, R. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90911-1 · Cited by 559
On the Treatment of Traumatic Tetanus,
CRUVEILHIER, M. (1824) · The Lancet · doi:10.1016/s0140-6736(02)93063-1 · Cited by 187
Doctors, Drug Companies, and Gifts
Chren, M. (1989) · JAMA · doi:10.1001/jama.1989.03430240084035 · Cited by 163
Cited by
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy
Van Zee, A. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.131714 · Cited by 910
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., et al. (2006) · JAMA · doi:10.1001/jama.295.4.429 · Cited by 695
Conflict of Interest in the Debate over Calcium-Channel Antagonists
Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380206 · Cited by 615
A Social Science Perspective on Gifts to Physicians From Industry
Dana, J. (2003) · JAMA · doi:10.1001/jama.290.2.252 · Cited by 594
Spurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000352 · Cited by 526
Steinman, M. A., Shlipak, M. G., & McPhee, S. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00660-x · Cited by 383
Katz, D., Caplan, A. L., & Merz, J. F. (2010) · The American Journal of Bioethics · doi:10.1080/15265161.2010.519226 · Cited by 355
Fickweiler, F., Fickweiler, W., & Urbach, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016408 · Cited by 293
Mitchell, A. P., Trivedi, N. U., Gennarelli, R. L., Chimonas, S., Tabatabai, S. M., Goldberg, J., Diaz, L. A., & Korenstein, D. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5665 · Cited by 262
Katz, D., Caplan, A. L., & Merz, J. F. (2003) · The American Journal of Bioethics · doi:10.1162/15265160360706552 · Cited by 250
Doris, J. M., & The Moral Psychology Research Group (2010) · doi:10.1093/acprof:oso/9780199582143.001.0001 · Cited by 227
Interactions between pharmaceutical representatives and doctors in training: A thematic review
Zipkin, D. A., & Steinman, M. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0134.x · Cited by 167
“However, the self-report and knowledge surveys among trainees reviewed here suggest that interactions with pharmaceutical representatives influence prescribing, which is also suggested by studies of behavioral outcomes in practicing physicians as well as the inherent goals of advertising and promotion in a profit-base…”
BackgroundDiner, B. M., Carpenter, C. R., O'Connell, T., Pang, P., Brown, M. D., Seupaul, R. A., Celentano, J. J., Mayer, D., & Members, K.-C. T. I. (2007) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2007.tb02381.x · Cited by 61
Off-Label Use vs Off-Label Marketing of Drugs
Van Norman, G. A. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.011 · Cited by 49
The hidden costs of financial conflicts of interest in medicine
Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000442694 · Cited by 25
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
Mitchell, A., Sarpatwari, A., & Bach, P. B. (2022) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-10041205 · Cited by 16
Metadata
- Authors
- Orlowski, J. P., & Wateska, L.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1992-07
- Volume
- 102
- Issue
- 1
- Pages
- 270-273
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2006072675
- Cited by
- 384
- References
- 3
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.